+ All Categories
Home > Documents > Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation...

Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation...

Date post: 31-Mar-2015
Category:
Upload: raymond-leavey
View: 219 times
Download: 2 times
Share this document with a friend
Popular Tags:
103
Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013
Transcript
Page 1: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Evidence-Based Public Health: A Course in Chronic Disease

Prevention

MODULE 7: Economic Evaluation

Kathy Gillespie

March 2013

Page 2: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

“An economist is a man who states the obvious in terms of the incomprehensible.”

Alfred A. Knopf

2

Page 3: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Kathleen N. Gillespie, PhD

314-977-8147

[email protected]

Page 4: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Learning Objectives

Be able to answer the following questions:

1. Why is economic evaluation needed?

2. What is economic evaluation? Are there different types?

3. When is an economic evaluation necessary or useful?

4

Page 5: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Learning Objectives

More questions…

4. How is an economic evaluation done?

5. Who can help me with an economic evaluation?

6. Where can I find information about economic evaluations?

5

Page 6: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Where This Module Fits

6

The green and blue sections, primarily

Page 7: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Next Module: Logic Model

EE helps with costs and objectives

7

Page 8: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Why?

Page 9: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Why EE?

• Evidence-based practice requires knowing – Does it work?– At what cost?

• EE starts after efficacy has been determined.

Want to promote interventions that work at a reasonable cost, i.e. that provide “good value for the money”

9

Page 10: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Examples

• Increasing Physical Activity: Evidence shows that the following will work (The Community Guide)– Community wide campaigns– School-based physical education– Street-scale urban design and land use

policies and practices– Social support interventions in community

settings

• Which to invest in? or a mix?10

Page 11: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Examples, cont.

• Budget cuts: A department’s budget must be cut by 5%. How to do this so as to minimize the effect on the public’s health?

• Grant awards: A number of applications have been received for a limited pool of grant dollars. How to select the winners?

11

Page 12: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Need to Weigh Costs and Benefits

• A scale can compare apples and oranges because both are measured by weight

• EE provides the scale – an agreed upon way to measure health benefits and costs

12

Page 13: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

What?

Page 14: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

What Is EE?

• EE examines the costs and benefits of alternative programs to inform decisions about the allocation of scarce resources using an established set of economic tools.

• There are four types of EE.

14

Page 15: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Types of Economic Evaluation• Cost-benefit (CBA)• Cost-utility (CUA)• Cost-effectiveness (CEA• Cost-minimization

The number of projects that can be compared declines as we move down the list.

15

Page 16: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

EE and Business

• EE methods are closely related to several business methods– Return on Investment, or ROI– Make or buy decision– A business plan

• Investment decision making

16

Page 17: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

It Helps to Have a Map

• What is the intervention?

• Who is the relevant group?

• How long should the group be followed?

• What can happen at each time period?

• DECISION ANALYSIS can provide the map.

17

Page 18: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Example Decision Tree

18Dowding D and Thompson C, Using decision analysis to integrate evidenceinto decision making, Evid Based Nursing, 2009 12: 102-104.

Page 19: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Components of Economic Evaluation in Public Health

19

Public Health

Program

EconomicInputs

HealthOutputs

CostsDirect CostsIndirect CostsAverted Treatment Costs

BenefitsYOLSQALYSDollars

Always compare a new program to some alternative.

Page 20: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Components of Economic Evaluation in Public Health

Costs A

New Program A Benefits A

Choice

Costs B Program B•Comparison program•May be new or old•Could be ‘doing nothing’

20

Benefits B

YOLSQALYSDollars

DirectIndirectAverted Treatment

Costs

Page 21: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

The Product of an EE

21

Incremental Costs

EE ratio =

IncrementalBenefits

Page 22: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

The EE Ratio

• The EE ratio is often called the Incremental Cost Effectiveness Ratio, or

ICER• Emphasizes that we are comparing 2 or

more interventions

22

Page 23: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Dimensions of Economic Evaluation

23

Type Inputs Outputs

CMA

ROI

CBA

CEA

CUA

Dollars

Dollars

Dollars

Dollars

Dollars

Natural Units Organization

Dollars Organization

Dollars Society

Natural Units Society

Utilities Society

Perspective

Page 24: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Every EE is Conducted from a Particular Perspective

• Perspective (or viewpoint) determines whose interests are paramount in the evaluation

• Perspective determines what costs and consequences are considered

• Perspective determines how the results are interpreted

24

Page 25: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Determining the Perspective• Single provider’s practice• FQHC• Healthcare system• Insurer – public (Medicaid) or private

(BCBS)• State agency• Federal program (CDC, Medicare)• Society

25

Page 26: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Example: Increasing Physical Activity

• Community wide campaigns

• Suppose a campaign would cost $150,000 and yield an improvement of 1,000 quality-adjusted life years

• ICER = $150/QALY

• Social support interventions in community settings

• Suppose this would cost $200,000 and yield 2,000 quality-adjusted life years

• ICER = $100/QALY

26

Page 27: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Some Assumptions of Economics

• Resources are scarce.• Human wants are unlimited, and more is

(almost) always preferred to less.• If there is perfect competition, the market

will do an efficient job of allocating scarce resources to maximize profits and satisfaction. Note: society may not consider this outcome equitable.

27

Page 28: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Some Assumptions of Economics

• If the market works well, then there are only 2 parties to each trade – a buyer and a seller – and they bear all the costs and reap all the benefits of the trade.

28

Page 29: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

When?

Page 30: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

When Is EE Needed?

• EE needed if there is market failure (inefficiency).– Perfect competition not present.– Could occur naturally or the market could be

‘broken’.

• EE helpful if there are concerns about inequity.

30

Page 31: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Inefficiency Reasons for EE • When the market fails, or is broken.

– Complex decisions with high stakes.– Little or no price information available.– High information costs to find out about the

product.• Markets involving externalities or public

goods.– Externalities are spillover effects from trades.– Public goods are non-excludable.

31

Page 32: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

When is EE needed? Really?

• Practically speaking, may be mandated or requested by funding agency.

• Useful when comparing options internally.• Useful when justifying programs externally.

32

Page 33: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Inequity Reasons for EE

• Social or government decision-making processes.– If the distribution of goods and services that

would emerge from the market is considered inequitable, then society can legislate, regulate, or tax/subsidize.

– EE measures the current or desired outcomes.

33

Page 34: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Public Health Requires EE

• Provides services when the market fails– WIC program, health clinics

• Complex decisions, high stakes - health and life

• Provides services with external benefits– Immunization programs, sanitation,

inspections– Tobacco control programs

34

Page 35: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Public Health Requires EE

• Provides public goods and services– Health monitoring and assessment– Social marketing and public information

campaigns

• Access to health and equity are often concerns

35

Page 36: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

How?

Page 37: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

The Product of an EE

37

Incremental Costs

EE ratio =

IncrementalBenefits

Page 38: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Quadrant IV Quadrant I

Quadrant IIQuadrant III

Saves money,Improves health

Costs money,Improves health

Costs money,Worsens health

Saves money,Worsens health

Aggregate Costs

Aggregate Health Benefits

Possible Outcomes of an EE

38

Page 39: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Measuring Costs

• All economic evaluation methods require listing and measurement of costs.

• One tricky point.– Mathematically, a benefit can be a negative

cost, and a cost can be a negative benefit.

39

Page 40: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Negative Costs and Benefits

• Whether some items are negative costs or benefits depends on the method.

• Makes a difference because we are constructing a ratio.

• General idea: all items falling on the health system are costs, positive or negative.

40

Page 41: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Types of Costs

• Direct (or program) costs • Indirect costs

– Time and travel costs to participants– Averted productivity losses (a negative cost)?– Cost of treatment during gained life

expectancy ?• Averted treatment costs (a negative cost)

41

Page 42: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Direct Costs

All costs of the intervention• Labor• Supplies• Rent• Utilities• Costs of treating side effects of the

intervention, if any

42

Page 43: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Indirect Costs

Also called spillover costs.• Time and travel costs to participants.• Costs to parties outside controlling program or

agency.• Averted productivity losses (a negative cost)?• Cost of treatment during gained life expectancy?

43

Page 44: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Averted Productivity Losses

• The present value of future wages gained.– The intervention increases the worker’s

longevity and/or reduces disability.

• Used in cost-benefit analyses.• Not included in cost-utility analyses.

– Double counting of the benefit.

44

Page 45: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Costs of Treatment During Gained Life Expectancy

• If the intervention saves a life, that person will die of something else later on. What are his/her expected total medical expenditures in the added life years? A controversial cost.

• Pro: these are expenses that would be avoided in the absence of the intervention, and therefore should be counted.

• Con: health expenses should not be singled out for inclusion.

45

Page 46: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Averted Treatment Costs

• The averted costs to society of treating persons for the disease are subtracted from total costs.

• Included in the cost side because they impact the health care budget.– A negative cost, not a benefit.

46

Page 47: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Measuring Benefits

• Benefits can be measured in many ways• Different units of measurement

– Dollars– Years of life saved– Quality adjusted years of life gained– Specific health outcome

• Different time frames for the outcome– Intermediate outcome– Final health outcomes

47

Page 48: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Measuring Benefits

Prevention poses special problems:• Benefits may be:

– small and cumulative.– complex and interrelated.

• Are difficult to measure or validate without large samples of panel data observed over long time periods.

• Consequently, often focus on intermediate outcomes.

48

Page 49: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Measuring Benefits

Prevention poses special problems:• Aim is often to change behavior among

more people.– Increases costs in the short term.

• Community versus individual approach.– Economies of scale possible.

• Provide walking trails; tax gasoline.

– Individual interventions often more costly.

49

Page 50: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

How to Put it Together?

• Have costs and benefits, how to put them together?

• Depends on the type of EE.

50

Page 51: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

DefinitionCost-minimization Analysis

51

• Populations served must be identical

• Outputs for all alternatives must be identical

• Timeframes must be the same• Search for alternative that yields

the lowest total cost

Page 52: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

CMA Example

52

• Deliver dental sealants to school children• Choose staffing that minimizes program

cost per studentCost per Student

0

5

10

15

20

25

30

1 2 3 4

Supervision Level

Co

st

No supervision General supervisionIndirect supervisionDirect supervision

Scherrer, CR, et al, Public Health Sealant Delivery Programs, Medical Decision Making, Nov-Dec 2007

Page 53: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

DefinitionReturn on Investment (ROI) or Business Case

• Answers question: Will an activity pay for itself?

• Analysis of net discounted cash flow to entity paying for an intervention• Typically short-term (1-5 years)• Perspective is key to determining costs

and consequences to include in analysis

53

Page 54: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Why develop a business case?

• A positive business case increases the probability that a prevention intervention will be sustained

• ROI analyses are most easily understood by administrators and budget officers

54

Brownson CA and Kilpatrick KE, Building a Business Case for Diabetes Self Management: A Handbook for Program Managers, Robert Wood Johnson Foundation, 2008 (available at www.diabetesinitiative.org/resources)

Page 55: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Return on Investment Example

55

• CareOregon (Portland): initiated case management for high-risk Medicaid enrollees with multiple comorbidities

• Study design: before-after design compared to baseline

• Investment costs: $526,290• Discounted savings: $6,423,776• Return on investment: 12.21: 1

Greene SB, et al, Searching for a business case for quality in Medicaid managed care, Health Care Management Review, 2008, 33(4), 350-360.

Page 56: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

DefinitionCost-benefit Analysis

• Cost-benefit analysis values both the costs and benefits of a program, project, or treatment in monetary terms.

• Result of analysis– The net benefit of the project (e.g. benefits

minus costs, or $12,000) OR– The ratio of costs divided by benefits (e.g. ½).

56

Page 57: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Cost Benefit Example• Intervention: Neighborhood-based

program to prevent teen pregnancy

• Program costs: $9,386 per participant per year

• Effects: reduced teen pregnancy from 94/1000 to 40/1000

• Cost: $26,142 per birth averted

• Saved: $81,256 society costs/birth averted

57

Rosenthal MS, et al., Economic Evaluation of a Comprehensive Teenage Pregnancy Prevention Program, Am J Prev Med 2009;37(6s1)

Page 58: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Example ICBR

58

ICB ratio = $26,142 = .322

$81,256

Smaller ratio is better

Page 59: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Cost-benefit Analysis

• Gold Standard for EE.• Allows for economic comparison of widely

disparate publicly funded programs in such areas as health, education, and the environment.

• Problem: valuing a life in monetary terms.

59

Page 60: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

DefinitionCost-effectiveness AnalysisCost-effectiveness analysis measures the

benefits of a program in naturally occurring health units, such as lives saved.

Example of a study result: $10,000 per life saved.

60

Page 61: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

CEA Example• Intervention: Smoking cessation

program in the workplace

• Effect measured: Number of people who quit smoking

• ICER = $596 cost per additional quitter

• This cost was less than “high intensity” interventions by clinicians

61

Tanaka H et al. Effectiveness of low-intensity intra-workplace intervention on smoking cessation in Japanese employees: a three year interventionTrial, J. Occup Health 2006; 48(3):175-82.

Page 62: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Cost-effectiveness Analysis

• CEA formerly most common form of EE conducted in health arena.

• Limited in its ability to report outcomes.– Often, there are multiple outcomes.

• Limited in its ability to compare interventions.

62

Page 63: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Three Projects Example

• A nursing program for newborns and their parents costs $50,000 per year and serves 50 infants with high-risk conditions

• A screening program that visits local malls and community centers costs $15,000 and provides information to about 5,000 persons

• A vaccination program costs $100,000 and provides vaccinations to 20,000 area children

63

Page 64: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Three Projects Example and CEA

• Nurses for infants

• Cost-effectiveness ratio is $50,000/50 infants or $1,000 per infant

• Screening program

• Cost-effectiveness ratio is $15,000/5000 or $3 per attendee

64

• Vaccination program

• Cost-effectiveness ratio is $100,000/20,000 or $5 per child

Page 65: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

DefinitionCost-utility Analysis

Cost-utility analysis compares the costs of different programs, projects, or treatments with their outcomes measured in “utility based units” which are related to a person’s health related quality of life.

Example of a study result: $10,000 per quality-adjusted life year, or $10,000/QALY.

65

Page 66: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

DefinitionCost-utility Analysis• Becoming the most common form of

analysis.• Widely used in Britain and Canada.• Allows comparison of many projects with

health-related outcomes.• Often called cost-effectiveness analysis;

closely related.

66

Page 67: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

CUA Formula

(direct costs+ indirect costs- averted treatment costs)

67

Quality adjustedlife years

Output of CUA is ‘cost per QALY’

=

Cost - utility ratio

Page 68: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Cost-utility Outcomes

• Outputs are measured in terms of a preference-based outcome measure.– Quality Adjusted Life Years (QALYS): the

number of years at full health that would be valued equivalently to a given number of years of life experienced with a disease or disability.

– Other measures are available, this is the most common.

68

Page 69: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Why Measure Quality of Life?

• Health care outcomes are multidimensional.- Length of life, or mortality.

- Quality of life, or morbidity.

• Allows for more than one disease or health problem to be compared.

• Considers the individual’s preference for health outcomes.

69

Page 70: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

How QALYS Are Measured

• One year of life in excellent health is assigned a value of 1; death is given a value of 0.

• A health state is described and its utility or quality elicited.

• The value assigned to quality of life is referred to as health utility.

70

0 1.5

Page 71: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Diabetes (Diet & Exercise)

Diabetes (Oral Agent)

Diabetes with Neuropathy

Diabetes with Neuro and High BP

Diabetes with Neuro, High BP, and Stroke

0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8

0.69

0.67

0.60

0.59

0.52

An example of estimated health utility values for diabetes

Coffey et al. 2002 Diabetes Care 71

Page 72: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

QALYs Gained from an intervention

death without the program

death with the program

without program

with program

He

alt

h r

ela

ted

qu

alit

y o

f lif

e

optimal health

Duration (years)0

1

72

Page 73: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Problems With QALYs

• Subjective and difficult to measure.

• Whose QALYs should count? A representative sample of the population or the affected group?

• QALY scales will differ depending upon factors such as age, gender

73

Page 74: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Stop Smoking Example

• After considering your community and its public health problems, your organization has identified smoking as a problem you can address.

• Two interventions are being considered; only one can be done.

74

Page 75: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Stop Smoking Example Using CUA

• Multicomponent interventions that include patient telephone support

• Suppose this would cost $150,000 and yield 1,000 quality-adjusted life years

• Healthcare provider reminder system

• Suppose this would cost $200,000 and yield 2,000 quality-adjusted life years

75

ICER for B vs. A = $50,000/1000 QALYs or $50/QALY

Page 76: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Cost Utility Example• Intervention: Diabetes self-management

programs in primary care settings

• Program costs: $866 per participant per year

• Effects: 87.5% benefited, A1c -.5%, total cholesterol. -10%

• ICER: $39,563/QALY saved

76

Brownson CA, et al., Cost-effectiveness of Diabetes Self-managementPrograms in Community Primary Care Settings, Diabetes Ed, v. 35, no.5, 2009

Page 77: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

How Do I Know If It’s Cost-Effective?

• Are we almost there yet?

• Once I have the ratio, how do I know if it’s too high, too low, or just right?

77

Page 78: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Is It Worth It?

• Results can be used internally or externally– To rank programs internally– To argue for external support

• Intermediate results, such as productivity gains, can be highlighted for some stakeholders

78

Page 79: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Using Results Internally

• For internal use– Rank options from lowest to highest ratio.– Start spending on lowest ratio, move on until

the money is exhausted– What have we spent before?

79

Page 80: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Using Results Externally

• The ICER is compared to a threshold value

• Suggested U.S. threshold is $50,000 to $100,000 per QALY at minimum

80

Page 81: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Exercise

81

Page 82: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Two Other Important Features

• Before study is complete, should consider– Discounting– Sensitivity analysis

82

Page 83: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Discounting

• Time value of money.– A dollar in the future will be worth less than a

dollar in the present.• Needed to compare present value and future

value of benefits from project.• Recommend a discount rate of 3-5%.• Discount rate chosen can affect results.

83

Page 84: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Discounting in Practice

• Suppose you want to find the present value of $100 received in 10 years. Several options for finding this.

• Tables in finance and accounting books.• Excel or other spreadsheet programs.• The internet: Google “present value

calculator” and several pop up.

84

Page 85: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Sensitivity Analysis

• EE is based on estimates and assumptions – want to vary them and see how robust the results are.

• Variables to test in sensitivity analysis should include the “top 3” or “top 5” “wobbliest” assumptions.

• Analysis should be redone varying the assumptions.

85

Page 86: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

EE Results Reporting

• The ICER(s) should be reported for the intervention(s) studied for the base case.

• ICERs may be reported for subgroups of the population.

• ICERs should be reported for different assumptions (sensitivity analysis).

86

Page 87: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

How is This Done in Practice?

• Back of the envelope EE– Draw a decision tree, follow the costs and

benefits, form the ratio– No economist required

• Primary data collection– Often alongside an intervention– Collect cost and benefit data– Economist works with team

87

Page 88: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

How is This Done in Practice?

• Synthetic EE– Follow a hypothetical cohort of persons– Use the literature to obtain cost and benefit

estimates– Rely on modeling and computer analysis– Economist leads the team

88

Page 89: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Who?

Page 90: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Who Does EE?

• Some economists are trained to do EE.• Most EEs require a multi-disciplinary team.• Few public health agencies have the

resources to have a staff economist – so think collaboratively – local colleges.

90

Page 91: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Where?

Page 92: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Web Resources

• http://www.thecommunityguide.org/econ/default.htm The economics section of The Community Guide, it includes systematic reviews of EEs for recommended activities.

• http://www.tufts-nemc.org/cearegistry/ The Cost Effectiveness Analysis Registry at Tufts – New England Medical Center. Includes EE results and QALY estimates for numerous conditions.

92

Page 93: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Web Resources

• http://www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME The Cochrane library, a reliable source of information on the effects of interventions in health care. Economic evaluations are available at

• http://www.mrw.interscience.wiley.com/cochrane/cochrane_cleed_articles_fs.html or by clicking from the web site above.

93

Page 94: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Web Resources

• http://www.york.ac.uk/inst/crd/ The Centre for Reviews and Dissemination at the University of York. Includes several searchable databases; of particular interest is the NHS Economic Evaluation Database (NHS EED), which provides article summaries, similar to the Community Guide.

• http://www.nice.org.uk The National Institute for Clinical Excellence. A more general database (the prior website is reachable through this site, for example) it includes RSS feed capabilities.

94

Page 95: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

NHS – EED

• Provides summaries of EE articles– Follows a standard format– Summary is about 2 pages or less– Can then click on full report, which may be

several pages

• Easily searchable– Good accessible instructions for searching

95

Page 96: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Sample NHS EED Results

Topic Hits

Smoking cessation 146

Diabetes prevention 279

Obesity 208

Obesity prevention 40

Physical activity 106

“Physical activity” 44

96

Page 97: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Reference Books

• Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. Third edition. Oxford: Oxford University Press; 2005.

• Muennig P (Contributing Editor, Kahn K). Designing and Conducting Cost-Effectiveness Analysis in Health and Medicine. San Francisco: Jossey-Bass, 2002. (2nd edition forthcoming).

97

Page 98: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Search Tips

• General strategy: search for the intervention of interest AND economic evaluation

• Often easier to run 2 searches – 1 for intervention and 1 for economic evaluation, and then combine them

98

Page 99: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Search Tips

• If you want any type of economic evaluation, search for ‘cost-benefit’ OR ‘cost effectiveness’ OR ‘cost utility’– “cost-effective” is a buzzword that will net a lot

of articles!• Articles in intervention journals will be

more verbose on the EE and terse on the intervention; articles in economic journals will be the reverse.

99

Page 100: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Economic Journals With an EE Focus

• Health Economics• Journal of Health Economics• Cost Effectiveness and Resource

Allocation• Health Technology Assessment• Applied Health Economics and Health

Policy• Value in Health

100

Page 101: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Summary

• Economic evaluation is the comparison of costs and benefits to determine the most efficient allocation of scarce resources.

• Economic evaluations can use existing or new information and can provide a reliable tool for decision making among public health professionals and policy makers.

• Though relatively sophisticated, the underlying logic and structure of an economic evaluation can be understood.

101

Page 102: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

Summary

• Several challenges (e.g., inconsistent quality, methodological issues, difficulties in implementation) should be kept in mind when considering the use of economic evaluations.

• Economic evaluation will be increasingly used, especially in times of limited public health resources, and practitioners must be able to understand them so that they can argue for setting appropriate public health priorities.

102

Page 103: Evidence-Based Public Health: A Course in Chronic Disease Prevention MODULE 7: Economic Evaluation Kathy Gillespie March 2013.

“It is our choices … that show what we truly are, far more than our abilities.”

J.K. Rowling, Harry Potter and The Chamber of Secrets, 1999

103


Recommended